John Mark Reimann, MBA
Product Development Director, Prime Therapeutics

John Mark (JM) Reimann leads Prime Therapeutics’ development of cost transparency tools and other eHealth products to enhance member and prescriber experience. He has an extensive track record of developing and managing innovative new products across multiple industries. JM holds a Bachelor of Science degree in electrical engineering from the U.S. Naval Academy and a Master of Business Administration from the University of Colorado.